RefluxStop™

RefluxStop™ restores the natural function of the esophageal sphincter without encircling the food passageway. #GERD #GORD #AcidReflux #GITwitter

[RefluxStop™ @RefluxStop]

The evidence behind RefluxStop™ keeps growing. The largest independent, real‑world study to date, evaluated safety outcomes for 602 GERD treated across 22 centers in six European countries with follow-up up to 6.75 years.

👉 Explore the study: https://t.co/xkW5YSNlqO

[RefluxStop™ @RefluxStop]

🚀 MD Anderson Hospiten-Madrid is the 20th RefluxStop® Center of Excellence in Spain!

🗞️ Read all about it in the press release: https://t.co/JlmHqr9vFE

[RefluxStop™ @RefluxStop]

What do RefluxStop™ clinical outcomes show about quality of life? Long-term follow-up data reported a 90% improvement in GERD-related quality-of-life scores, sustained through 5 years after the procedure.¹

📚 See the study: https://t.co/ANCi1vOQPx

[RefluxStop™ @RefluxStop]

❓GERD patients ask, "Will this still work years from now?" In a prospective multicenter RefluxStop™ study, 97.9% of study patients did not need daily PPIs after surgery & throughout the 5 years they were followed. See this study and more: https://t.co/za5tygdQTU

[RefluxStop™ @RefluxStop]

We were thrilled to see long-term follow-up data from 82 Swiss patients treated with RefluxStop® presented by Dr. med. Yves Borbély (Inselspital, Bern University Hospital, Switzerland) at #DDW2026.

🗞️ Read all about it in the press release: https://t.co/IzV9oz5azt

@DDWMeeting

[RefluxStop™ @RefluxStop]

🇮🇹 Cost-effectiveness study from the Italian healthcare payer perspective showed @RefluxStop cost-effective at a €50,000/QALY threshold, with 100% probability vs. PPIs & MSA, and 97% probability vs. Nissen fundoplication.

🗞️ Read the press release: https://t.co/4jnbQh8wbv

[RefluxStop™ @RefluxStop]

🚀 BIG NEWS! The final responses for the FDA PMA Application for Refluxstop® have been submitted! This significant milestone represents one of the final steps on the way to FDA approval.

🗞️ Read all about it in the press release: https://t.co/IyhgfCfjL4

[RefluxStop™ @RefluxStop]

📣 RefluxStop® in the news: https://t.co/rVaKEWID5J highlights the largest independent real-world RefluxStop® study to date, including 602 patients.

🗞️ Read the article: https://t.co/4auAz8gqgN

📚Read more RefluxStop® scientific publications: https://t.co/AYYGcKOaFZ

[RefluxStop™ @RefluxStop]

Congratulations to everyone at @DDWMeeting on an incredible event. This year was bigger than ever, with even more lively discussions and exciting learning. We couldn't be prouder to have been here and part of it all. Thank you! We can't wait for next year. Here's to #DDW2027!

[RefluxStop™ @RefluxStop]

Last call at #DDW2026! 📢
The Exhibit Hall is open until 4 p.m. CDT today.
Stop by to discuss RefluxStop® 5-year data outcomes with our Clinical Team and get your questions answered in person before we head home! 🩺

Learn more about Refluxstop®: https://t.co/9CXLoqMRMD

[RefluxStop™ @RefluxStop]

We’re often asked: “How does RefluxStop® reduce the negative side effects of anti-reflux surgery?”

The answer lies in its unique mechanism of action. Learn more from the RefluxStop® Clinical Team at #DDDW2026
@DDWMeeting
Learn more: https://t.co/9CXLoqMRMD

[RefluxStop™ @RefluxStop]

Today! LONG-TERM FOLLOW-UP OF THE REFLUXSTOP PROCEDURE TO ADDRESS GASTROESOPHAGEAL REFLUX DISEASE

Session Type: Poster
Session Title:
GERD: Endoscopic and Surgical Therapy
📆Sunday, May 3
⏰12:30-1:30 PM CT

Learn more about RefluxStop®: https://t.co/za5tygdQTU

#DDW2026

[RefluxStop™ @RefluxStop]

🚀 RefluxStop® will be here before you know it. Our Clinical Team is standing by at #DDW2026 to discuss outcomes from Europe & the unique mechanism of action of RefluxStop®. Stop by & learn all you can.

We're at the booth 9:30 AM-4:00 PM CT.
Learn more: https://t.co/TXxkXIbqWK

[RefluxStop™ @RefluxStop]

Dr. med. Borbély will present a poster tomorrow @DDWMeeting

LONG-TERM FOLLOW-UP OF THE REFLUXSTOP PROCEDURE TO ADDRESS GASTROESOPHAGEAL REFLUX DISEASE

Session Type: Poster
Session Title:
GERD: Endoscopic and Surgical Therapy
📆Sunday, May 3
⏰12:30-1:30 PM CT
#DDW2026

[RefluxStop™ @RefluxStop]

Exciting to see this independent poster at #DDW2026

Poster Title: LONG-TERM FOLLOW-UP OF THE REFLUXSTOP PROCEDURE TO ADDRESS GASTROESOPHAGEAL REFLUX DISEASE

Session Type: Poster
Session Title:
GERD: Endoscopic and Surgical Therapy

📆Sunday, May 3
⏰12:30-1:30 PM CT

[RefluxStop™ @RefluxStop]

✈️ On your way to #DDW2026? Enjoy this Chicago playlist! https://t.co/t9XEeN3KuF

Pending FDA Approval. RefluxStop® is not available for sale in the US and Canada. Please contact your Implantica representative for availability in your region. [email protected]

[RefluxStop™ @RefluxStop]

Can you see RefluxStop® on the horizon? Get ready & come learn all you can at #DDW2026. Meet the RefluxStop® Clinical Team to discuss real-world data from Europe and the unique mechanism of action.

📍Booth #1916
⏰ 9:30 AM-4:00 PM CT
📆 May 3- 5

@DDWMeeting

[RefluxStop™ @RefluxStop]

#DDW2026 is your opportunity to get caught up on RefluxStop® before it's available in the U.S. Learn from the RefluxStop® Clinical Team at our booth and get ready for patient questions:
📍Booth #1916
⏰ 9:30 AM-4:00 PM CT
📆 May 3- 5

✏️Learn more: https://t.co/AYYGcKOaFZ

[RefluxStop™ @RefluxStop]

🔥GERD is an anatomical problem causing the body's natural Anti‑Reflux Barrier (ARB) to stop working as it should. By restoring this original anatomy, RefluxStop™ allows the body's natural barrier to function normally again.

✅ Get to know RefluxStop™: https://t.co/TXxkXIbqWK

[RefluxStop™ @RefluxStop]

Don't miss your chance to learn about RefluxStop® at #DDW2026. It's the only surgical solution of its kind! Meet the RefluxStop® Clinical Team:
📍Booth #1916
⏰ 9:30 AM-4:00 PM
📆 Sunday, May 3-Tuesday, May 5

✏️Get your questions ready: https://t.co/WJ0EWxT37a